Glucagonoma syndrome: Survival 24 years following diagnosis

Digestive Surgery

Volumn 16, Issue 1, 1999, Pages 68-71

  Nightingale, K J ^a,b   Davies, M G ^a   Kingsnorth, A N ^b  

^a Department of Dermatology ^*  (United Kingdom)

^b DERRIFORD HOSPITAL   (United Kingdom)

Author keywords

Glucagonoma; Long term survival; Necrolytic migratory erythema; Octreotide

Indexed keywords

AGED; ARTICLE; CASE REPORT; DIABETES MELLITUS; DIARRHEA; ERYTHEMA; FEMALE; GLUCAGONOMA; HUMAN; PANCREAS RESECTION; PROGNOSIS; SPLENECTOMY; STOMATITIS; SURVIVAL; SYMPTOM; WEIGHT REDUCTION;

AGED; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; GLUCAGON; GLUCAGONOMA; HUMANS; PANCREATECTOMY; PANCREATIC NEOPLASMS; SYNDROME; TIME FACTORS; TREATMENT OUTCOME;

EID: 0033040512     PISSN: 02534886     EISSN: None     Source Type: Journal    
DOI: 10.1159/000018696     Document Type: Article

References (5)

1. Sweet RD: A dermatosis specifically associated with a tumour of pancreatic alpha cells. Br J Dermatol 1974;90:301-308.
2. Wermers RA, Fatourechi V, Wynne AG, Kvols LK, Lloyd RV: The glucagonoma syndrome. Clinical and pathological features in 21 patients. Medicine 1996;75:53-63.
3. Kasper CS: Necrolytic migratory erythema: Unresolved problems in diagnosis and pathogenesis. A case report and literature review. Cutis 1992;49:120-122, 125-128.
4. Andersson K, Wangberg B, Tissell LE, Nilsson O, Fjalling M, Forssell-Aronsson E, Ahren B, Ahlman H: Glukagonom. Tumorsjukdom med mangfasetterad klinisk bild. Lakartidningen 1996;93:2935-2939.
5. Arnaud A, Fetissof F, Lorette G, Reigner J, Bertrand G, Lecomte P: Le syndrome du glucagonome: Trois nouveaux cas. Rev Méd Interne 1992;13:103-108.